Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle

https://doi.org/10.1016/0952-0600(90)90009-8Get rights and content

Abstract

The muscarinic receptor subtype involved in human airway smooth muscle contraction was characterised for the first time, using subtype-selective muscarinic antagonists. It was demonstrated that methacholine-induced contraction of central (trachea) and peripheral (small bronchi) airway smooth muscle preparations was antagonised by pirenzepine, AF-DX 116, 4-DAMP methobromide, hexahydrosiladifenidol, and methoctramine with pA2-values characteristic of M3 (smooth muscle/glandular) muscarinic receptors. Since these pA2-values demonstrate significant correlations with those found in bovine and guinea-pig tracheal smooth muscle contraction, it is concluded that these animal tissues provide a good model for the study of M3 subtype-selective muscarinic antagonists to be used as bronchodilators.

References (30)

  • PJ Barnes

    Cholinergic control of airway smooth muscle

    Am Rev Respir Dis

    (1987)
  • NJ Gross

    Anticholinergic agents in chronic bronchitis and emphysema

    Postgrad Med J

    (1987)
  • TI Bonner et al.

    Identification of a family of muscarinic acetylcholine receptor genes

    Science

    (1987)
  • NJ Buckley et al.

    Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells

    Mol Pharmacol

    (1989)
  • JWJ Lammers et al.

    The role of pirenzepine-sensitive (M1) muscarinic receptors in vagally mediated bronchoconstriction in humans

    Am Rev Respir Dis

    (1989)
  • Cited by (0)

    View full text